midazolam has been researched along with dinoprostone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hellige, G; Klockgether-Radke, AP; Neumann, P; Pawlowski, P | 1 |
Chapman, S; Gilat, E; Kadar, T | 1 |
Chapman, S; Egoz, I; Gilat, E; Grauer, E; Kadar, T; Rabinovitz, I; Raveh, L; Yaakov, G | 1 |
Chapman, S; Egoz, I; Gez, R; Grauer, E; Lazar, S | 1 |
Baranes, S; Chapman, S; David, T; Dekel Jaoui, H; Efrati, R; Egoz, I; Gez, R; Gore, A; Grauer, E; Lazar, S; Neufeld-Cohen, A; Yampolsky, M | 1 |
6 other study(ies) available for midazolam and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mechanisms involved in the relaxing effect of midazolam on coronary arteries.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Coronary Vessels; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hypnotics and Sedatives; Hypoglycemic Agents; In Vitro Techniques; Indomethacin; Midazolam; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Potassium Chloride; Swine; Tetraethylammonium; Vasodilation | 2005 |
Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain.
Topics: Animals; Anticonvulsants; Brain Chemistry; Chemical Warfare Agents; Cholinesterase Inhibitors; Cytokines; Dinoprostone; Electroencephalography; Electrophysiology; Hippocampus; Inflammation; Interleukin-1; Interleukin-6; Male; Midazolam; Rats; Rats, Sprague-Dawley; Sarin; Seizures; Tumor Necrosis Factor-alpha | 2006 |
Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam.
Topics: Analysis of Variance; Animals; Brain Injuries; Carrier Proteins; Cholinesterase Inhibitors; Cytokines; Dinoprostone; Drug Administration Schedule; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Hypnotics and Sedatives; Male; Maze Learning; Midazolam; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sarin; Severity of Illness Index; Time Factors | 2015 |
Time dependent dual effect of anti-inflammatory treatments on sarin-induced brain inflammation: Suggested role of prostaglandins.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Atropine; Brain Diseases; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dinoprostone; Encephalitis; Male; Midazolam; Nerve Agents; Neuroprotective Agents; Prostaglandins; Rats; Rats, Sprague-Dawley; Sarin; Seizures; Trimedoxime | 2019 |
Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carrier Proteins; Dinoprostone; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Injections, Intramuscular; Injections, Intraperitoneal; Ketamine; Male; Midazolam; Open Field Test; Rats, Sprague-Dawley; Receptors, GABA-A; Recognition, Psychology; Sarin; Status Epilepticus; Time Factors; Valproic Acid | 2021 |